• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮下植入式心律转复除颤器预防心源性猝死的效果及并发症:一项叙述性综述

Effects and Complications of Subcutaneous Implantable Cardioverter-Defibrillator in the Prevention of Sudden Cardiac Death: A Narrative Review.

作者信息

Pagore Prasad A, Gaidhane Shilpa A

机构信息

Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences, Wardha, IND.

School of Epidemiology and Public Health, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences, Wardha, IND.

出版信息

Cureus. 2022 Oct 11;14(10):e30170. doi: 10.7759/cureus.30170. eCollection 2022 Oct.

DOI:10.7759/cureus.30170
PMID:36397900
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9648676/
Abstract

An implantable cardioverter-defibrillator (ICD) is one of those devices that is a big boom for the prevention of sudden deaths due to heart failure. This particular device has been in use for just a couple of years, but its impact in the domain has brought about a considerable change in the way a specific issue of the cardiovascular system is tackled. Although subcutaneous or hypodermic implantable cardioverter-defibrillator (S-ICD) is considered to be a better alternative as far as transvenous implantable cardioverter-defibrillator (TV-ICD) is concerned, the former, being a newer introduction in the market, needs to be assessed in depth to clearly understand its effects and complications. Various types of research have been conducted on the efficacy of this device, and in most of the studies, the supremacy of this device is clearly evident when compared with other devices that are used for the same purpose. Better innovations in subcutaneous or hypodermic implantable cardioverter-defibrillators would enable them to be manufactured in a more efficient and cost-effective way so that a huge lot of people are benefited from this device. This review article is a whole peep into the various studies done in this domain, thereby providing adequate scientific insights about subcutaneous or hypodermic implantable cardioverter-defibrillators in a very simple and comprehensive manner.

摘要

植入式心脏复律除颤器(ICD)是预防心力衰竭导致猝死的重要设备之一。这种特殊的设备投入使用仅数年,但它在该领域的影响已使心血管系统特定问题的处理方式发生了显著变化。尽管就经静脉植入式心脏复律除颤器(TV-ICD)而言,皮下植入式心脏复律除颤器(S-ICD)被认为是更好的选择,但前者作为市场上的新进入者,需要进行深入评估,以清楚了解其效果和并发症。针对该设备的疗效已开展了各类研究,在大多数研究中,与用于相同目的的其他设备相比,该设备的优势明显。皮下植入式心脏复律除颤器的更好创新将使其能以更高效且具成本效益的方式制造出来,从而让大量人群受益于该设备。这篇综述文章全面审视了该领域的各类研究,从而以非常简单且全面的方式提供了关于皮下植入式心脏复律除颤器的充分科学见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9af/9648676/4157c093293d/cureus-0014-00000030170-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9af/9648676/4157c093293d/cureus-0014-00000030170-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9af/9648676/4157c093293d/cureus-0014-00000030170-i01.jpg

相似文献

1
Effects and Complications of Subcutaneous Implantable Cardioverter-Defibrillator in the Prevention of Sudden Cardiac Death: A Narrative Review.皮下植入式心律转复除颤器预防心源性猝死的效果及并发症:一项叙述性综述
Cureus. 2022 Oct 11;14(10):e30170. doi: 10.7759/cureus.30170. eCollection 2022 Oct.
2
Efficacy and Complications of Subcutaneous versus Conventional Cardioverter Defibrillators: A Systematic Review and Meta-analysis.皮下与传统心脏除颤器的疗效和并发症:系统评价和荟萃分析。
Curr Cardiol Rev. 2022;18(3):e081221198647. doi: 10.2174/1573403X17666211208100151.
3
Subcutaneous implantable cardioverter defibrillator indication in prevention of sudden cardiac death in difficult clinical situations: A French expert position paper.皮下植入式心律转复除颤器在困难临床情况下预防心源性猝死的适应证:法国专家立场文件。
Arch Cardiovasc Dis. 2020 May;113(5):359-366. doi: 10.1016/j.acvd.2020.03.011. Epub 2020 Apr 22.
4
Subcutaneous versus transvenous implantable cardioverter defibrillators in children and young adults: A meta-analysis.皮下与经静脉植入式心律转复除颤器在儿童和青少年中的比较:一项荟萃分析。
Pacing Clin Electrophysiol. 2022 Dec;45(12):1409-1414. doi: 10.1111/pace.14603. Epub 2022 Oct 27.
5
Shock Without Wires: A Look at Subcutaneous Implantable Cardioverter-Defibrillator Compared to Transvenous Implantable Cardioverter-Defibrillator for Ventricular Arrhythmias.无导线除颤器:皮下植入式除颤器与经静脉植入式除颤器治疗室性心律失常的比较。
Curr Probl Cardiol. 2022 Sep;47(9):100927. doi: 10.1016/j.cpcardiol.2021.100927. Epub 2021 Jul 3.
6
Non-traditional implantable cardioverter-defibrillator configurations and insertion techniques: a review of contemporary options.非传统型植入式心脏复律除颤器的配置和插入技术:当代选择的回顾。
Europace. 2022 Feb 2;24(2):181-192. doi: 10.1093/europace/euab178.
7
[Sudden cardiac death in the youth. Is the new subcutaneous implantable cardioverter defibrillator S-ICD an alternative solution?].[青年心脏性猝死。新型皮下植入式心律转复除颤器S-ICD是一种替代解决方案吗?]
Ann Cardiol Angeiol (Paris). 2015 Feb;64(1):27-31. doi: 10.1016/j.ancard.2014.08.018. Epub 2014 Sep 18.
8
Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Meta-Analysis of Case-Control Studies.皮下与经静脉植入式心脏除颤器治疗:病例对照研究的荟萃分析。
JACC Clin Electrophysiol. 2017 Dec 26;3(13):1475-1483. doi: 10.1016/j.jacep.2017.07.017. Epub 2017 Sep 27.
9
Prevention of Sudden Cardiac Death: Focus on the Subcutaneous Implantable Cardioverter-Defibrillator.心脏性猝死的预防:聚焦皮下植入式心律转复除颤器
High Blood Press Cardiovasc Prev. 2020 Aug;27(4):291-297. doi: 10.1007/s40292-020-00394-x. Epub 2020 Jun 9.
10
Subcutaneous implantable cardioverter defibrillator: Can it overtake its transvenous counterpart.皮下植入式心律转复除颤器:它能否超越经静脉植入式心律转复除颤器。
Pacing Clin Electrophysiol. 2021 Aug;44(8):1413-1420. doi: 10.1111/pace.14246. Epub 2021 May 22.

本文引用的文献

1
Risk Factors for Sudden Death in Athletes, Is There a Role for Screening?运动员猝死的风险因素,筛查是否有作用?
Curr Cardiovasc Risk Rep. 2022;16(10):97-109. doi: 10.1007/s12170-022-00697-9. Epub 2022 Jul 4.
2
Circadian rhythms, cardiac arrhythmias and sudden death.昼夜节律、心律失常与猝死
Front Biosci (Landmark Ed). 2021 Nov 30;26(11):1305-1311. doi: 10.52586/5025.
3
Preventive implantable cardioverter defibrillator therapy in contemporary clinical practice: need for more stringent selection criteria.当代临床实践中的预防性植入式心脏转复除颤器治疗:需要更严格的选择标准。
ESC Heart Fail. 2021 Oct;8(5):3656-3662. doi: 10.1002/ehf2.13506. Epub 2021 Aug 1.
4
Dutch Outcome in Implantable Cardioverter-Defibrillator Therapy: Implantable Cardioverter-Defibrillator-Related Complications in a Contemporary Primary Prevention Cohort.荷兰植入型心律转复除颤器治疗结果:当代一级预防队列中与植入型心律转复除颤器相关的并发症。
J Am Heart Assoc. 2021 Apr 6;10(7):e018063. doi: 10.1161/JAHA.120.018063. Epub 2021 Mar 31.
5
Sudden cardiac death-update.突发心脏性死亡更新。
Int J Legal Med. 2021 Mar;135(2):483-495. doi: 10.1007/s00414-020-02481-z. Epub 2020 Dec 21.
6
Subcutaneous Implantable Cardioverter-Defibrillator Lead Extraction: First Multicenter French Experience.皮下植入式心脏复律除颤器导线拔除:法国多中心的首次经验。
JACC Clin Electrophysiol. 2020 Jul;6(7):863-870. doi: 10.1016/j.jacep.2020.04.012.
7
Subcutaneous implantable cardioverter defibrillator indication in prevention of sudden cardiac death in difficult clinical situations: A French expert position paper.皮下植入式心律转复除颤器在困难临床情况下预防心源性猝死的适应证:法国专家立场文件。
Arch Cardiovasc Dis. 2020 May;113(5):359-366. doi: 10.1016/j.acvd.2020.03.011. Epub 2020 Apr 22.
8
Diagnosis and management of subcutaneous implantable cardioverter-defibrillator infections based on process mapping.基于流程映射的皮下植入式心律转复除颤器感染的诊断和管理。
Pacing Clin Electrophysiol. 2020 Sep;43(9):958-965. doi: 10.1111/pace.13902. Epub 2020 Apr 23.
9
Automatic implantable cardioverter defibrillator: when not to implant.
Monaldi Arch Chest Dis. 2020 Feb 21;90(1). doi: 10.4081/monaldi.2020.1225.
10
The subcutaneous implantable cardioverter-defibrillator in review.皮下植入式心律转复除颤器述评。
Am Heart J. 2019 Nov;217:131-139. doi: 10.1016/j.ahj.2019.08.010. Epub 2019 Aug 17.